Literature DB >> 12552087

HLA-G gene repression is reversed by demethylation.

Philippe Moreau1, Gael Mouillot, Philippe Rousseau, Celine Marcou, Jean Dausset, Edgardo D Carosella.   

Abstract

The HLA-G molecule plays an important role in immune tolerance, protecting the fetus from maternal immune attack, and probably contributes to graft tolerance and tumor escape from the host immune system. HLA-G expression is tightly regulated and involves mechanisms acting in part at the transcriptional level. Nevertheless, almost all regulatory sequences that govern constitutive and inducible HLA class I gene transcription are disrupted in the HLA-G gene promoter, suggesting an unusual regulatory process. In further investigating the molecular mechanisms of HLA-G gene activation, we evaluated the influence of epigenetic mechanisms on seven HLA-G-negative cell lines that exhibit various phenotypes. Exposure of cells to histone deacetylase inhibitors, or to the demethylating agent 5-aza-2'-deoxycytidine, revealed that HLA-G gene transcription is inhibited by DNA methylation. Reversal of methylation-mediated repression may directly induce HLA-G cell-surface expression, supporting the idea that HLA-G might be activated by such a mechanism during malignancy, inflammation, and allogenic reactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552087      PMCID: PMC298749          DOI: 10.1073/pnas.0337539100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  70 in total

1.  Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element.

Authors:  S J Gobin; M van Zutphen; A M Woltman; P J van den Elsen
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

2.  Molecular mechanisms controlling constitutive and IFN-gamma-inducible HLA-G expression in various cell types.

Authors:  S Lefebvre; P Moreau; V Guiard; E C Ibrahim; F Adrian-Cabestre; C Menier; J Dausset; E D Carosella; P Paul
Journal:  J Reprod Immunol       Date:  1999-07       Impact factor: 4.054

3.  IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes.

Authors:  P Moreau; F Adrian-Cabestre; C Menier; V Guiard; L Gourand; J Dausset; E D Carosella; P Paul
Journal:  Int Immunol       Date:  1999-05       Impact factor: 4.823

4.  Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor.

Authors:  M Ponte; C Cantoni; R Biassoni; A Tradori-Cappai; G Bentivoglio; C Vitale; S Bertone; A Moretta; L Moretta; M C Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 5.  Shared regulatory elements in the promoters of MHC class I and class II genes.

Authors:  P J van den Elsen; A Peijnenburg; M C van Eggermond; S J Gobin
Journal:  Immunol Today       Date:  1998-07

6.  Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G.

Authors:  A Blaschitz; F Lenfant; V Mallet; M Hartmann; A Bensussan; D E Geraghty; P Le Bouteiller; G Dohr
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

7.  Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins.

Authors:  C Lurquin; C De Smet; F Brasseur; F Muscatelli; V Martelange; E De Plaen; R Brasseur; A P Monaco; T Boon
Journal:  Genomics       Date:  1997-12-15       Impact factor: 5.736

8.  HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.

Authors:  P Paul; N Rouas-Freiss; I Khalil-Daher; P Moreau; B Riteau; F A Le Gal; M F Avril; J Dausset; J G Guillet; E D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

9.  Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules.

Authors:  M Colonna; J Samaridis; M Cella; L Angman; R L Allen; C A O'Callaghan; R Dunbar; G S Ogg; V Cerundolo; A Rolink
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

10.  HLA-G class I gene expression in normal and malignant hematopoietic cells.

Authors:  L Amiot; M Onno; B Drénou; C Monvoisin; R Fauchet
Journal:  Hum Immunol       Date:  1998-08       Impact factor: 2.850

View more
  42 in total

Review 1.  Does nitric oxide play a role in maternal tolerance towards the foetus?

Authors:  A González; A S López; E Alegre; J L Alcázar; N López-Moratalla
Journal:  J Physiol Biochem       Date:  2004-09       Impact factor: 4.158

2.  Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21.

Authors:  Dan Nicolae; Nancy J Cox; Lucille A Lester; Daniel Schneider; Zheng Tan; Christine Billstrand; Susan Kuldanek; Joseph Donfack; Paul Kogut; Nina M Patel; Jeffrey Goodenbour; Timothy Howard; Raoul Wolf; Gerard H Koppelman; Steven R White; Rodney Parry; Dirkje S Postma; Deborah Meyers; Eugene R Bleecker; Joan S Hunt; Julian Solway; Carole Ober
Journal:  Am J Hum Genet       Date:  2004-12-20       Impact factor: 11.025

Review 3.  Nanoparticles targeting HLA-G for gene therapy in cancer.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Med Oncol       Date:  2011-04-17       Impact factor: 3.064

4.  Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma.

Authors:  Simon Jasinski-Bergner; Christine Stoehr; Juergen Bukur; Chiara Massa; Juliane Braun; Stefan Hüttelmaier; Verena Spath; Roland Wartenberg; Wolfgang Legal; Helge Taubert; Sven Wach; Bernd Wullich; Arndt Hartmann; Barbara Seliger
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

5.  Modulation of HLA-G expression in human neural cells after neurotropic viral infections.

Authors:  Monique Lafon; Christophe Prehaud; Françoise Megret; Mireille Lafage; Gaël Mouillot; Michèle Roa; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy.

Authors:  Kei Ishibashi; Takumi Kumai; Takayuki Ohkuri; Akemi Kosaka; Toshihiro Nagato; Yui Hirata; Kenzo Ohara; Kensuke Oikawa; Naoko Aoki; Naoko Akiyama; Masatoshi Sado; Masahiro Kitada; Yasuaki Harabuchi; Esteban Celis; Hiroya Kobayashi
Journal:  Oncoimmunology       Date:  2016-03-30       Impact factor: 8.110

Review 7.  Soluble HLA-G: Are they clinically relevant?

Authors:  Vito Pistoia; Fabio Morandi; Xinhui Wang; Soldano Ferrone
Journal:  Semin Cancer Biol       Date:  2007-07-31       Impact factor: 15.707

8.  Variation in the HLA-G promoter region influences miscarriage rates.

Authors:  Carole Ober; Carrie L Aldrich; Inna Chervoneva; Christine Billstrand; Fedik Rahimov; Heather L Gray; Terry Hyslop
Journal:  Am J Hum Genet       Date:  2003-04-29       Impact factor: 11.025

9.  In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.

Authors:  Philippe Rousseau; Krzysztof Masternak; Michal Krawczyk; Walter Reith; Jean Dausset; Edgardo D Carosella; Philippe Moreau
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

10.  Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.

Authors:  Isabela J Wastowski; Renata T Simões; Layale Yaghi; Eduardo A Donadi; João T Pancoto; Isabelle Poras; Emmanuèle Lechapt-Zalcman; Myriam Bernaudin; Samuel Valable; Carlos G Carlotti; Sébastien Flajollet; Stine S Jensen; Soldano Ferrone; Edgardo D Carosella; Bjarne W Kristensen; Philippe Moreau
Journal:  Am J Pathol       Date:  2012-12-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.